Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction
International Journal of Molecular Sciences · 04.01.2023 · 24 (2) · 972
DOI: 10.3390/ijms24020972 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.01.2023. Verfasst von Weronika Dymara-Konopka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Perinatology, Medical University of Lublin, 8 Jaczewskiego Street, 20-095 Lublin, Poland. Hauptthemen laut MEDLINE: Pre-Eclampsia, Placenta Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.
Abstract (Originalsprache)
The purpose of this study was to evaluate serum levels of anti- and pro-angiogenic substances measured using enzyme-linked immunosorbent assays and their ratios in pregnancies complicated by different clinical subsets of placental ischemic syndrome: preeclampsia and/or fetal growth restriction. A prospective case-control study was performed consisting of 77 singleton pregnancies complicated by preeclampsia, preeclampsia with concurrent fetal growth restriction (FGR), and isolated normotensive FGR pairwise matched by gestational age with healthy pregnancies. The entire study cohort was analyzed with respect to adverse pregnancy outcomes that occurred. In all investigated subgroups, placental growth factor (PlGF) was lower and soluble endoglin (sEng), the soluble fms-like tyrosine kinase-1—sFlt-1/PlGF and sFlt-1*sEng/PlGF ratios were higher than in the control group. The differences were most strongly pronounced in the PE with concurrent FGR group and in the sFlt-1/PlGF ratio. The highest sFlt-1 values in preeclamptic patients suggest that this substance may be responsible for reaching the threshold needed for PE to develop as a maternal manifestation of ischemic placental disease. The FGR is characterized by an elevated maternal sFlt-1/PlGF ratio, which boosts at the moment of indicated delivery due to fetal risk. We concluded that angiogenic imbalance is reflective of placental disease regardless of its clinical manifestation in the mother, and may be used as support for the diagnosis and prognosis of FGR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Perinatology, Medical University of Lublin, 8 Jaczewskiego Street, 20-095 Lublin, Poland.
- Department of Experimental Immunology, Medical University of Lublin, 4a Chodźki Street, 20-093 Lublin, Poland.
- Department of Pathobiochemistry and Interdisciplinary Applications of Ion Chromatography, Biomedical Sciences, Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, Poland.
ORCID-Profile: Weronika Dymara-Konopka, Marzena Laskowska, Ewelina Grywalska, Anna Błażewicz
Förderung
- Medical University of Lublin
Zitieren
APA
Dymara-Konopka, W., Laskowska, M., Grywalska, E., Hymos, A., Błażewicz, A., & Leszczyńska-Gorzelak, B. (2023). Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction. International Journal of Molecular Sciences, 24(2), 972. https://doi.org/10.3390/ijms24020972
Vancouver
Dymara-Konopka W, Laskowska M, Grywalska E, Hymos A, Błażewicz A, Leszczyńska-Gorzelak B. Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction. International Journal of Molecular Sciences. 2023;24(2):972. doi:10.3390/ijms24020972
BibTeX
@article{DymaraKonopka2023,
author = {Dymara-Konopka, Weronika and Laskowska, Marzena and Grywalska, Ewelina and Hymos, Anna and Błażewicz, Anna and Leszczyńska-Gorzelak, Bożena},
title = {Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {972},
doi = {10.3390/ijms24020972}
}
EUVIMED